Skip to content

Effect of 3 months continuous intake of LPS-supplement on the maintenance of healthy blood vessels and blood flow in 65 years old from 20 years old : parallel double-blind randomized controlled study.

Effect of 3 months continuous intake of LPS-supplement on the maintenance of healthy blood vessels and blood flow in 65 years old from 20 years old : parallel double-blind randomized controlled study. - Double-blind study about the effectiveness of LPS-supplement on the maintenance of healthy blood vessels and blood flow.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019210
Enrollment
60
Registered
2015-10-02
Start date
2015-10-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake of the test-supplement for 3 months Intake of the placebo for 3 months

Sponsors

Linking Setouchi Innate immune Network
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Who can understand the contents of the study and can consent to the participation to the study after receiving the explanation. 2) Persons older than 20 years and younger than 74 years at the date of consent whose blood test values at the time of screening are in range shown in the point. LDL (mg/dL)60-139, HDL(mg/dL):40-119, triglyceride(mg/dL):30-199, WBC(times1,000/microliter):3.2-8.9, RBC(times10,000/microliter):male 400-599,female:360-549, AST(GOT):(U/L)0-35, ALT(GPT) (U/L):0-40, creatinine(mg/dL):male:under 1.09 female:under 0.79, HbA1c(parcent):under 5.9

Exclusion criteria

Exclusion criteria: 1) Whose blood markers levels examined at the time of screening are not normal. 2) Who is using drug or food that principle-investigator or sub-investigator judged to affect the result of the study. 3) Who are participating or are planning to participate to other interventional study. 4) Who have donated blood more than 400mL within the last three months or more than 200mL within the last one month before the date of consent. 5) Who is judged to be unsuitable for this study by principle-investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Blood test (oxidized LDL, LDL, HDL, triglyceride)

Secondary

MeasureTime frame
Blood test (WBC, RBC, HbA1c, AST (GOT), ALT (GPT), creatinine, CRP, IgA) Physical examination (body weight, body fat, arteriosclerosis examination, blood flow measurement) Questionnaire (neck stiffness, feeling of coldness, feeling of hotness, bowel movement, sleep, common cold)

Countries

Japan

Contacts

Public ContactYuko Nakamoto

Linking Setouchi Innate immune Network Secretariat

npolsinlsin@lsin.org087-813-9201

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026